These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15508405)

  • 1. [Treatment of chronic hepatitis B].
    Lengyel G; Fehér J
    Orv Hetil; 2004 Sep; 145(36):1861-3. PubMed ID: 15508405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protocol for the antiviral therapy of chronic hepatitis B].
    ;
    Orv Hetil; 2008 Dec; 149(49):2341-3. PubMed ID: 19042187
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protocol for the treatment of chronic viral hepatitis].
    Dalmi L; Gervain J; Horváth G; Hunyady B; Ibrányi E; Makara M; Pár A; Szalay F; Tornai I; Telegdy L; ;
    Orv Hetil; 2008 Jan; 149(3):129-35. PubMed ID: 18194921
    [No Abstract]   [Full Text] [Related]  

  • 4. Applicability of cost-effectiveness analysis to management of chronic hepatitis B.
    Dan YY; Lim SG
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1357-9. PubMed ID: 17716341
    [No Abstract]   [Full Text] [Related]  

  • 5. Peginterferon and lamivudine for hepatitis B.
    Assy NN; Hussein O
    N Engl J Med; 2004 Dec; 351(27):2879; author reply 2879. PubMed ID: 15625344
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
    Song K; Rajvanshi P
    N Engl J Med; 2005 Oct; 353(15):1630-1; author reply 1630-1. PubMed ID: 16221792
    [No Abstract]   [Full Text] [Related]  

  • 7. The maze of treatments for hepatitis B.
    Lok AS
    N Engl J Med; 2005 Jun; 352(26):2743-6. PubMed ID: 15987924
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
    Pár A; Tornai I; Szalay F
    Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment options in chronic hepatitis B].
    Nitschmann S
    Internist (Berl); 2006 Mar; 47(3):308-9; discussion 309-10. PubMed ID: 16485097
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
    Orlent H
    N Engl J Med; 2005 Oct; 353(15):1630-1; author reply 1630-1. PubMed ID: 16224825
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with interferons (including pegylated interferons) in patients with hepatitis B.
    Cooksley WG
    Semin Liver Dis; 2004; 24 Suppl 1():45-53. PubMed ID: 15192801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon therapy for chronic hepatitis B].
    Hige S; Sho T; Nakanishi M; Chuma M
    Nihon Rinsho; 2011 May; 69 Suppl 4():481-5. PubMed ID: 22096965
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon.
    Brunetto MR; Oliveri F; Colombatto P; Coco B; Ciccorossi P; Bonino F
    J Hepatol; 2003; 39 Suppl 1():S164-7. PubMed ID: 14708697
    [No Abstract]   [Full Text] [Related]  

  • 14. Pegylated interferon-alpha2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B.
    ter Borg MJ; Janssen HL
    Ann Intern Med; 2005 Sep; 143(5):391; author reply 391-2. PubMed ID: 16144900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current issues in antiviral therapy of chronic hepatitis B and C].
    Bakulin IG
    Eksp Klin Gastroenterol; 2010; (5):3-9. PubMed ID: 20731128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.
    Flink HJ; Buster EH; Merican I; Nevens F; Kitis G; Cianciara J; de Vries RA; Hansen BE; Schalm SW; Janssen HL
    Gut; 2007 Oct; 56(10):1485-6. PubMed ID: 17872587
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
    Buster EH; Janssen HL
    Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
    Cooksley G
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):12-3. PubMed ID: 16265091
    [No Abstract]   [Full Text] [Related]  

  • 19. [PEG-interferons: significance for the treatment of viral hepatitis B and C].
    Wedemeyer H; Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S68-75. PubMed ID: 11450618
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiviral therapy in children with chronic hepatitis B and children with chronic hepatitis C].
    Zhang H; Zhu S
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):563-6. PubMed ID: 25224229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.